病毒学失败是指ART治疗未能将HIV RNA水平保持在200拷贝/mL以下。 当前的HIV RNA检测中,经常会出现20至200拷贝/mL之间的间歇性病毒反弹(称为“blip”),这种现象比较常见,不应因此更换治疗方案,但需要关注患者的ART依从性,并检查是否有干扰药物或...
病毒学失败是指ART治疗未能将HIV RNA水平保持在200拷贝/mL以下。 当前的HIV RNA检测中,经常会出现20至200拷贝/mL之间的间歇性病毒反弹(称为“blip”),这种现象比较常见,不应因此更换治疗方案,但需要关注患者的ART依从性,并检查是否有干扰药物或补充剂的使用,例如含多价阳离子的物质(钙、镁、铁或锌等),这些物质...
6. Michael Sabranski, Matteo Vassallo, Joss de Wet, et al. Bictegravir/emtricitabine/ tenofovir alafenamide (B/F/TAF) in antiretroviral treatmentnaïve (TN) and -experienced (TE) people with HIV (PWH): 3-year effectiveness and safety outcomes in the BICSTaR observational cohort. EACS 2023...
emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials[J]. The Lancet HIV, 2020, 7(6): e389-e400. ...
7. Trottier B, et al. Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) for the treatment of people living with HIV: 24-month (24M) analyses by age, race, sex, adherence and late presentation in a multi-...
et al. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials[J]. The Lancet HIV, 2020, 7(6): ...
[10]Mounzer, K., et al., Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens. Open forum infectious diseases, 2022. 9(3): p. ofac018-ofac018. [11]Schuettfort G, Cabello A, Cotter A G, et al. Reasons for Choice of Antir...
The FDA has also approved a monthly injection of two medications to treat HIV in certain people. Your Treatment Plan Your doctor will recommend the treatment that’s best for you, based on things like: What strain of the virus you have and whether it’s drug-resistant What other medical co...
Adherence to antiretroviral treatment (ART) of HIV-infected persons with or without injection drug use (IDU) or in a drug addiction treatment program: the Swiss HIV cohort studyHuber MD, MiloLedergerber, BrunoFurrer, HansjakobElzi, Luigia
et al. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. Lancet HIV. 2020;7...